Description: There are practical and conceptual aspects underlying (re)insurability. Practically, something or someone is insurable if an insurer is willing provide insurance coverage at a price the applicant is willing to pay. In contrast, a conceptual view of (re)insurabiity incorporates a range of more complex factors usually considered in the insurance process. This article discusses these two approaches.

Description: With more than 24 years of experience in the reinsurance market, Bruno Freire is the CEO and one of the co-founders of Austral Re, along with Vinci Partners, a private equity firm. Austral Re is a Brazilian- based multiline reinsurer which that writes business across Latin America. It has grown organically throughout the last 13 years, and had its credit rating upgraded to A- in 2023 by AM Best (it also has AAAbr from S&P). Before joining Austral, Bruno had been a reinsurance broker at Aon Re for more than 10 years, having witnessed the opening of the reinsurance market in Brazil. As we will be seen in his interview the following, he believes in a data driven analytic approach, client focused but with an underwriting mindset, as well as a strong support from actuaries and technology as key instruments to run a reinsurance company successfully.

Description: Re/insurance rates have been increasing since 2018, although pricing momentum has decelerated recently. Insurers and reinsurers are working to enhance profitability and improve the value proposition for clients in an environment of uncertainty about natural catastrophes, COVID-19-related losses, and social inflation, among other factors. This article describes drivers of the current underwriting cycle, compares it with past cycles, and provides considerations for the future.

Description: Exploration of the relationship between insuretech and reinsurance in Life and P&C

Description: Article looks at various catastrophic events in past years specifically around insurance claims and the negative impact this has had on the insurance/reinsurance industries. It suggests better communication strategies for companies when dealing with the public.

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: Article about talent crisis in insurance industry

Description: As a newly elected SOA Reinsurance Section Chair for 2025, Yiru (Eve) Sun described the Section's plan to better bridge the gap between insurers and reinsurers, to expand research initiatives and presentation priorities, and to enhance the growth of the Section and the future Community. This year the Section will celebrate the 40th anniversary of the Reinsurance Newsletter with a retrospective on industry developments, continue the “Reinsurance Point of View ReView Short Video Series”, conduct industry surveys, and host more virtual and in-person networking events.

Description: Leadership lessons for actuaries. Insights into what Asset Intensive Reinsurance is all about.

Description: Meditation on life, choices and events during the COVID-19 pandemic